MMP9 and breast carcinoma: Gu et al. constructed GO-PAMAM dendrimers to deliver doxorubicin (DOX) and MMP-9 shRNA plasmids, showing notable transfection efficacy and ample therapeutic effects in turning the expression of MMP-9 proteins down in MCF-7 cells in breast cancer [150].